about
Potential impact of co-infections and co-morbidities prevalent in Africa on influenza severity and frequency: a systematic reviewMortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009.Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012.Mortality Associated With Seasonal and Pandemic Influenza Among Pregnant and Nonpregnant Women of Childbearing Age in a High-HIV-Prevalence Setting-South Africa, 1999-2009.Influenza Sentinel Surveillance among Patients with Influenza-Like-Illness and Severe Acute Respiratory Illness within the Framework of the National Reference Laboratory, Niger, 2009-2013.Comparing Influenza Positivity Rates by Real-Time RT-PCR, Elisa and Viral Culture Methods in Côte D'Ivoire, West Africa, in 2009.Influenza surveillance in 15 countries in Africa, 2006-2010.Introduction of 2009 pandemic influenza A virus subtype H1N1 into South Africa: clinical presentation, epidemiology, and transmissibility of the first 100 casesInfluenza surveillance in Zambia, 2008-2009.2009 Pandemic influenza A virus subtype H1N1 in Morocco, 2009-2010: epidemiology, transmissibility, and factors associated with fatal cases.Risk mapping of Rinderpest sero-prevalence in Central and Southern Somalia based on spatial and network risk factors.Enterovirus D68 and other enterovirus serotypes identified in South African patients with severe acute respiratory illness, 2009-2011.Risk Factors for Influenza-Associated Severe Acute Respiratory Illness Hospitalization in South Africa, 2012-2015Evaluation of the influenza sentinel surveillance system in Madagascar, 2009-2014.Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014.Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South AfricaComparison of quantitative real-time PCR and direct immunofluorescence for the detection of Pneumocystis jiroveciiEstimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016.Genetic diversity and molecular epidemiology of human rhinoviruses in South AfricaReproductive number and serial interval of the first wave of influenza A(H1N1)pdm09 virus in South Africa.Measles outbreak in South Africa: epidemiology of laboratory-confirmed measles cases and assessment of intervention, 2009-2011Epidemiology of viral-associated acute lower respiratory tract infection among children <5 years of age in a high HIV prevalence setting, South Africa, 2009-2012Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007-2012.Challenges of using molecular serotyping for surveillance of pneumococcal disease.Influenza virus infection is associated with increased risk of death amongst patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010-2011.Epidemiology of severe acute respiratory illness (SARI) among adults and children aged ≥5 years in a high HIV-prevalence setting, 2009-2012.Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005-2009.Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013.Deaths associated with respiratory syncytial and influenza viruses among persons ≥5 years of age in HIV-prevalent area, South Africa, 1998-2009(1).Evaluation of two influenza surveillance systems in South Africa.Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010-2013.Excess Mortality Associated with Influenza among Tuberculosis Deaths in South Africa, 1999-2009Determining the Provincial and National Burden of Influenza-Associated Severe Acute Respiratory Illness in South Africa Using a Rapid Assessment Methodology.Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa.Viral and bacterial etiology of severe acute respiratory illness among children < 5 years of age without influenza in Niger.Parainfluenza Virus Infection Among Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Children and Adults Hospitalized for Severe Acute Respiratory Illness in South Africa, 2009-2014.Development of a respiratory severity score for hospitalized adults in a high HIV-prevalence setting-South Africa, 2010-2011.Knowledge, attitudes and practices of South African healthcare workers regarding the prevention and treatment of influenza among HIV-infected individuals.
P50
Q23909568-B1153028-A84F-4D74-837E-096487C279AEQ30359417-39A1C3BF-C145-4BA4-A5BE-C612CC17DAC3Q30363955-C888E5DD-8F06-4A23-840F-C19BAF6C06A6Q30375504-6B4A37D9-981C-4ED1-8276-59420B2968F2Q30377374-44750683-0F3E-4A77-AAB8-6406B0953C1EQ30401458-F599E192-E37C-4F0B-B5F6-717140D6F562Q30423845-7E00EEA9-736F-4F74-95D2-1F5AC9D7E844Q30423852-284352B1-16F7-49B4-AD39-2CAB6FC61C1BQ30423868-B273146B-AA6D-4712-9381-C1EE3EB90D31Q30423893-F0D77DBA-D3F2-4FCF-828C-C8FD95C99C8DQ33567276-B391714F-E1E0-4DD4-9210-E79C7BBC4A0EQ33619882-752644B4-F449-4A08-BC90-20DC97BE8059Q33629197-AA99FA9B-6DA5-4041-8C5B-B2E5A14E691CQ33640915-B860F020-BD1A-466A-AAC9-91B898BA494FQ33727940-D4EAE64C-5981-4CB4-B8B5-A5D32A382B45Q33865533-C2F94338-28F8-40EC-AF0A-CC60CF01F04EQ33880693-E39E96A6-7B9B-4BAD-ABE5-5D881893F0F0Q33884440-E330A0C4-F5DA-4C30-935E-5B1C2EFB3DD7Q33908117-2148A32F-A52D-48F0-B632-B75C973B613FQ34274941-D261B407-537D-4E34-B853-96973C7CA221Q34482384-39D07703-06B1-4C2C-8BC4-E0AF8D066696Q34598162-34C9602B-5B25-4668-8190-6107EBDAA06CQ34772743-5EC01CCC-B209-4ACC-B170-BBE4F3D4863AQ34781034-D5974D30-E06E-4410-9E7D-314D97A8B9B2Q35035741-3698778D-C3B7-4CDA-A913-B9420F9DF905Q35047483-9A0E5023-D7B6-4D6F-A510-EE899984FA28Q35112120-107C67D7-220C-4988-BF9B-B10F34C9D41BQ35149045-25D00E71-FD6A-4A61-AA06-E1212B473CA9Q35192751-5F204F83-8BC9-4611-874B-89078F66D23DQ35229634-51A6A6E3-B7B0-4D15-9A80-4780033EC9F0Q35231313-DB22B176-EB6D-4E08-94AC-EB6E532C4C9EQ35557368-FEFE46C9-5B37-4F36-89EB-E6F762913804Q35664030-7B131F11-758C-485C-8956-774F0D7DC1C7Q35685999-783FF048-3186-4F26-8638-58404F3A1E9AQ35761073-BE7EC963-03C9-4BC8-95F1-9467E3BBB4CFQ35819384-F3D1DD0C-5C95-4AED-B0C2-0D34C1830888Q35841170-ACAFA374-AAD5-460B-97B8-6CC29FF0FB23Q36241627-1D796E46-F37E-4757-B5DE-C8D54E3DAB53Q36266736-7A74C72D-2B52-41CA-8D03-42F8B88A212CQ36310855-B0F5ED1C-F38B-42EB-8CE7-9C8CF1E2EB0D
P50
description
researcher ORCID ID = 0000-0003-4395-347X
@en
wetenschapper
@nl
name
Stefano Tempia
@ast
Stefano Tempia
@en
Stefano Tempia
@es
Stefano Tempia
@nl
type
label
Stefano Tempia
@ast
Stefano Tempia
@en
Stefano Tempia
@es
Stefano Tempia
@nl
prefLabel
Stefano Tempia
@ast
Stefano Tempia
@en
Stefano Tempia
@es
Stefano Tempia
@nl
P106
P21
P31
P496
0000-0003-4395-347X